Hoynoza Technologies

Discover, select or investigate an ingredient before further development.

Ingredient development combines production-process research, candidate screening and mechanism investigation to characterise candidates and identify questions for further testing.

Fermentation, biological production or cellular research scoped to the ingredient brief.

Evaluate ingredient activity and product benefits using methods suited to the question, including chemical and optical assays, cell and tissue models, and human outcome studies. Laboratory mechanisms support development but do not automatically establish visible benefits in people. Human results apply to the tested product, population, endpoint and protocol.

Cytokine cascade modulation testing examines how an ingredient affects linked inflammatory signals in skin-cell or tissue models. Cytokine panels and pathway measurements characterize responses to a defined challenge, including UV where relevant, rather than guaranteeing irritation-free product use.

Growth-factor stimulation testing measures whether ingredients change production or release of selected growth factors in hair-relevant cells. It investigates signaling associated with follicle function without directly proving hair regeneration or increased growth.

Create a formula and prototypes, then prepare their transfer to production.

Formulation develops a cosmetic composition from a brief or refines an existing formula. It includes ingredient selection, prototype preparation, development-phase testing and technical records, with specialist work chosen according to the product’s needs.

Technical records needed to reproduce and transfer the formula.

Trial samples to evaluate texture, appearance and use.

Development checks to choose between prototypes; not a shelf-life guarantee.

Improve performance, texture, stability or cost within an existing brief.

A new formula developed from your product brief.

Preclinical safety testing investigates potential adverse effects of cosmetic ingredients and formulations using cell-based and tissue-based methods. Cytotoxicity, irritation and sensitization assessments answer different questions and contribute to, rather than replace, a product safety evaluation.

Laboratory hazard evidence is distinct from human tolerance, an exposure-based safety assessment, SPF efficacy and a finished regulatory dossier.

Cell-viability and concentration-response data; not a complete safety conclusion.

Measure release, absorption or localisation using an appropriate sample and protocol.

Penetration and delivery studies investigate where a cosmetic ingredient goes after application and how its release or availability depends on the formulation. The appropriate service depends on whether the question concerns release, uptake, permeation or location within skin.